UK Competition Regulator Steps Up Hydrocortisone Probe
Executive Summary
Two generics firms have been provisionally found to have breached competition law by reaching agreements intended to delay the entry of competing products.
You may also be interested in...
Firms Vow To Appeal After CMA’s £260m Hydrocortisone Fines In UK
Firms censured by the UK’s CMA competition regulator over illegal deals that drove up the price of hydrocortisone for around a decade have vowed to appeal against the decision and the imposition of fines totaling more than £260m.
Firms Vow To Appeal After CMA’s £260m Hydrocortisone Fines In UK
Firms censured by the UK’s CMA competition regulator over illegal deals that drove up the price of hydrocortisone for around a decade have vowed to appeal against the decision and the imposition of fines totaling more than £260m.
Four Accused By UK's CMA On Nortriptyline
King Pharmaceuticals and Auden Mckenzie have been accused by the UK’s competition regulator of sharing out the supply of nortriptyline 10mg and 25mg tablets, in a case that also implicates Alissa and Lexon for exchanging commercially-sensitive information as part of an effort to drive up prices.